DONGGUK UNIVERSITY GYEONGJU CAMPUS INDUSTRY-ACADEMY COOPERATION FOUNDATION;동국대학교 경주캠퍼스 산학협력단
发明人:
LEE, Ju Hee,이주희,KIM, Ok Hyeon,김옥현
申请号：
KRKR2019/012203
公开号：
WO2020/060264A1
申请日:
2019.09.20
申请国别(地区):
KR
年份:
2020
代理人:
摘要：
The present invention relates to a composition comprising a sulforaphane derivative for preventing, treating, or alleviating muscle atrophy and sarcopenia. The composition is not toxic to C2C12 cells and can effectively suppress muscle atrophy, thereby finding advantageous applications in the prevention, treatment, or alleviation of muscle atrophy.La présente invention concerne une composition comprenant un dérivé de sulforaphane destinée à prévenir, à traiter ou à soulager l'atrophie musculaire et la sarcopénie. La composition n'est pas toxique pour les cellules C2C12 et permet de supprimer efficacement l'atrophie musculaire, ce qui permet de trouver des applications avantageuses dans la prévention, le traitement ou le soulagement de l'atrophie musculaire.본 발명은 설포라판 유도체를 포함하는 근위축 및 근감소 예방, 치료 또는 개선용 조성물에 관한 것으로, C2C12 세포에 독성이 없으면서도, 근위축을 효과적으로 억제할 수 있으므로, 근위축 예방, 치료 또는 개선에 유용하게 활용할 수 있다.
